DENVER, U.S./WILKES-BARRE, Pa., U.S.: Vivos Therapeutics, an American company that seeks to find the best evidence-based treatment for obstructive sleep apnea (OSA), has recently collaborated with one of the nation’s largest dental product and equipment distributors, Benco Dental, to promote the Vivos System apnea treatment in the U.S. and expand the company’s client base. As part of the partnership, Benco will offer its customers a unique in-person opportunity to obtain more information on the treatment and to find out how it benefits sleep apnea sufferers and dental practitioners in a series of events that will take place from October this year.
Sleep disorders, including sleep apnea, are a major health issue in the U.S. According to the American Sleep Apnea Association, approximately 22 million Americans suffer from sleep apnea and 80% of OSA cases are undiagnosed. “Sleep apnea is a serious and growing health epidemic facing America,” said Kirk Huntsman, CEO at Vivos. “Our newly formed partnership with Benco Dental will allow our revolutionary technology to reach dentists and their patients throughout the U.S. and introduce them to our VIP program designed specially to help clinicians achieve success, regardless of their experience levels in sleep dentistry.”
The Vivos System uses a proprietary variety of oral appliances to restore and reopen the upper airway without the patient having to undergo surgery. The procedure is completely noninvasive and does not require the patient to take any pharmaceutical drugs. At the beginning of the treatment, the patient is prescribed a custom-made oral appliance and is asked to wear it at night while sleeping. Patients can start seeing the results after 18 months of continued use.
“Our company has a long history of bringing to market innovative products from trailblazing companies,” said Chuck Cohen, Managing Director at Benco Dental. “The Vivos System stands as one of those potential game changers because it’s a possible curative solution—a technology-enabled, multidisciplinary, comprehensive solution—that dentists are uniquely qualified to apply. The Vivos vision of empowering clinicians to rid the world of OSA is keenly aligned with Benco’s own commitment to driving dentistry forward and opening new worlds of treatment possibilities,” he concluded.
More information about the treatment can be found here.
Tags:
From 4 to 7 October, the world of endodontics will be meeting in the South Korean capital of Seoul for the 11th International Federation of Endodontic ...
GLASGOW, UK: At the recent British Orthodontic Conference in Glasgow, the British Orthodontic Society (BOS) and the Oral Health Foundation (OHF) have taken...
LONDON, UK: A recent UK study has pointed to the need for education and awareness in dental teams to avoid diagnostic overshadowing—misattributing ...
LONDON, UK: Antibiotic resistance is one of the key challenges that dental and medical professionals will face over the coming decades, yet its causes and ...
Orthognathic surgery has been performed routinely since the mid- 1970s to correct severe skeletal malocclusion. Since its inception, various forms of ...
LONDON, UK: The hormonal changes that women experience in the menopause may cause cognitive, physical and psychological symptoms, and these are well ...
NEW YORK, U.S.: Certain traits may define a type of obstructive sleep apnea (OSA) that can be effectively treated with an oral appliance, according to new ...
NAMUR, Belgium: To date, continuous positive airway pressure is still the industry standard when it comes to treating sleep apnoea. However, the cumbersome ...
COPENHAGEN, Denmark: To offer a simpler, more effective and quicker workflow, 3Shape recently announced a new collaboration with sleep apparatus producer ...
TURKU, Finland: During the first wave of the pandemic, the number of hospitalisations for SARS-CoV-2 infections in Finland was relatively low compared with ...
Live webinar
Thu. 18 July 2024
8:00 pm EST (New York)
Live webinar
Tue. 6 August 2024
6:00 pm EST (New York)
Live webinar
Tue. 13 August 2024
7:00 pm EST (New York)
Live webinar
Wed. 14 August 2024
12:30 pm EST (New York)
Live webinar
Wed. 21 August 2024
9:00 am EST (New York)
Dr. Jim Lai DMD, MSc(Perio), EdD, FRCD(C)
Live webinar
Wed. 28 August 2024
8:00 pm EST (New York)
Live webinar
Mon. 2 September 2024
5:00 am EST (New York)
amazing product